Gut microbiota of obese, type 2 diabetic individuals is enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after weight loss

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 16, Issue 2, 2016, Pages 99-106

  Remely, Marlene ^a   Hippe, Berit ^a   Zanner, Julia ^a   Aumueller, Eva ^a   Brath, Helmuth ^b   Haslberger, Alexander G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Vienna Tech   (Austria)

Author keywords

Firmicutes Bacteroidetes ratio; Fragment length polymorphism analysis; GLP 1 agonist therapy; Metabolic syndrome

Indexed keywords

EXENDIN 4; LIRAGLUTIDE;

ADULT; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; BACTEROIDES; BODY MASS; CONTROLLED STUDY; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENE SEQUENCE; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; LACTOBACILLUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL COUNSELING; OBESITY; PEPTOSTREPTOCOCCUS ANAEROBIUS; POLYMERASE CHAIN REACTION; WEIGHT REDUCTION;

EID: 84991406526     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530316666160831093813     Document Type: Article

References (70)

1. Osborn, O.; Olefsky, J. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med., 2012, 18, 363-374.
2. Cani, P.; Biblioni, R.; Knauf, C.; Waget, A.; Neyrinck, A.; Delzenne, N. and Burcellin, R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat dietinduced obesity and diabetes in mice. Diabetes, 2008, 57, 1470-1481.
3. Cani, P.; Possemiers, S.; Van de Wiele, T.; Guiot, Y.; Everard, A.; Rottier, O.; Geurts, L.; Naslain, D.; Neyrinck, A.; Lambert, D.; Muccioli, G. and Delzenne, N. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut, 2009, 58, 1091-1103.
4. Karlsson, F.H.; Ussery, D.W.; Nielsen, J. and Nookaew, I. A closer look at bacteroides: phylogenetic relationship and genomic implications of a life in the human gut. Microb. Ecol., 2010, 61(3), 473-485.
5. Remely, M.; Dworzak, S.; Hippe, B.; Zwielehner, J.; Aumuller, E.; Brath, H. and Haslberger, A.G. Abundance and diversity of microbiota in type 2 diabetes and obesity. J. Diabetes Metab., 2013, 4, 253.
6. Eckburg, P.; Bik, E.; Bernstein, C.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.; Nelson, K. and Relman, D. Diversity of the human intestinal microbial flora. Science, 2005, 308, 1635-1638.
7. Suau, A.; Bonnet, R.; Sutren, M.; Godon, J.; Gibson, G.; Collins, M. and Dore, J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol., 1999, 65, 4799-4807.
8. Turnbaugh, P.; Ley, R.; Mahowald, M.; Magrini, V.; Mardis, E. and Gordon, J. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 2006, 1027-1031.
9. Ley, R.; Turnbaugh, P.; Klein, S. and Gordon, J. Microbial ecology: human gut microbes associated with obesity. Nature, 2006, 444, 1022-1023.
10. Backhed, F.; Ding, H.; Wang, T.; Hooper, L.V.; Koh, G.Y.; Nagy, A.; Semenkovich, C.F. and Gordon, J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA, 2004, 101(44), 15718-15723.
11. Turnbaugh, P.J.; Ley, R.E.; Mahowald, M.A.; Magrini, V.; Mardis, E.R. and Gordon, J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 2006, 444, 1027-1031.
12. Schwiertz, A.; Taras, D.; Schafer, K.; Beijer, S.; Bos, N.; Donus, C. and Hardt, P. Microbiota and SCFA in lean and overweight healthy subjects. Obesity, 2010, 18, 190-195.
13. Jumbertz, R.; Le, D.; Turnbaugh, P.; Trinidad, C.; Bogardus, C.; Gordon, J. and Krakoff, J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorptions in humans. Am. J. Clin. Nutr., 2011, 94, 58-65.
14. Diamant, M.; Blaak, E.E. and de Vos, W.M. Do nutrient-gutmicrobiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes. Rev., 2011, 12, 272-281.
15. Cani, P.D.; Bibiloni, R.; Knauf, C.; Waget, A.; Neyrinck, A.M.; Delzenne, N.M. and Burcelin, R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat dietinduced obesity and diabetes in mice. Diabetes, 2008, 57, 1470-1481.
16. Cani, P.D. and Delzenne, N.M. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr. Opin. Pharmacol., 2009, 9, 737-743.
17. DiBaise, J.K.; Zhang, H.; Crowell, M.D.; Krajmalnik-Brown, R.; Decker, G.A. and Rittmann, B.E. Gut microbiota and its possible relationship with obesity. Mayo. Clin. Proc., 2008, 83, 460-469.
18. Sotos, M.; Nadal, I.; Marti, A.; Martinez, A.; Martin-Matillas, M.; Campoy, C.; Puertollano, M.; Warnberg, J.; Marcos, A. and Sanz, Y. Gut microbes and obesity in adolescents. Proc. Nutr. Soc., 2008, 67, E20.
19. Santacruz, A.; Marcos, A.; Warnberg, J.; Marti, A.; Martin-Matillas, M.; Campoy, C.; Moreno, L.; Veiga, O.; Redondo-Figuero, C.; Garagorri, J.; Azona, C.; Delgado, M.; Garcia-Fuentes, M.; Collado, M. and Sanz, Y. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity, 2009, 17, 1906-1915.
20. Ivanov, II and Honda, K. Intestinal commensal microbes as immune modulators. Cell Host Microbe., 2012, 12, 496-508.
21. Mazmanian, S.K.; Round, J.L. and Kasper, D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature, 2008, 453, 620-625.
22. Li, M.; Wang, B.; Zhang, M.; Rantalainen, M.; Wang, S.; Zhou, H.; Zhang, Y.; Shen, J.; Pang, X.; Zhang, M.; Wei, H.; Chen, Y.; Lu, H.; Zuo, J.; Su, M.; Qiu, Y.; Jia, W.; Xiao, C.; Smith, L.; Yang, S.; Holmes, E.; Tang, H.; Zhao, G.; Nicholson, J.; Li, L. and Zhao, L. Symbiotic gut microbes modulate human metabolic phenotypes. Proc. Nat. Acad. Sci. USA, 2008, 105, 2117-2122.
23. Sokol, H.; Pigneur, B.; Watterlot, L.; Lakhdari, O.; Bermudez-Humaran, L.; Gratadoux, J.; Blugeon, S.; Bridonneau, C.; Furet, J.; Corthier, G.; Grangette, C.; Vasquez, N.; Pochart, P.; Trugnan, G.; Thomas, G.; Blottiere, H.; Dore, J.; Marteu, P.; Seksik, P. and Langella, P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA, 2008, 105, 16731-16736.
24. Remely, M.; Aumueller, E.; Merold, C.; Dworzak, S.; Hippe, B.; Zanner, J.; Pointner, A.; Brath, H. and Haslberger, A.G. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene, 2013, 537, 85-92.
25. Furet, J.; Kong, L.; Tap, J.; Poitou, C.; Basdevant, A.; Bouillot, J.; Mariat, D.; Corthier, G.; Dore, J.; Henegar, C.; Rizkalla, S. and Clement, K. Differential adaption of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes, 2010, 59, 3049-3057.
26. Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; Shen, D.; Peng, Y.; Zhang, D.; Jie, Z.; Wu, W.; Qin, Y.; Xue, W.; Li, J.; Han, L.; Lu, D.; Wu, P.; Dai, Y.; Sun, X.; Li, Z.; Tang, A.; Zhong, S.; Li, X.; Chen, W.; Xu, R.; Wang, M.; Feng, Q.; Gong, M.; Yu, J.; Zhang, Y.; Zhang, M.; Hansen, T.; Sanchez, G.; Raes, J.; Falony, G.; Okuda, S.; Almeida, M.; LeChatelier, E.; Renault, P.; Pons, N.; Batto, J-M.; Zhang, Z.; Chen, H.; Yang, R.; Zheng, W.; Li, S.; Yang, H.; Wang, J.; Ehrlich, S.D.; Nielsen, R.; Pedersen, O.; Kristiansen, K. and Wang, J. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 2012, 490, 55-60.
27. Balmurugan, R.; George, G.; Kabeerdoss, J.; Hepsiba, J.; Chandragunasekaran, A. and Ramakrishna, B. Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br. J. Nutr., 2010, 103, 335-338.
28. Zhang, X.; Shen, D.; Fang, Z.; Jie, Z.; Zhang, C.; Chen, Y. and Ji, L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One, 2013 8, e71108.
29. Karlsson, C.; Molin, G.; Falk, F.; Johansson Hagslatt, M.; Jakesevic, M.; Hakansson, A.; Jeppsson, B.; Westrom, B. and Ahrne, S. Effect on weight gain and gut microbiota in rats given bacterial supplements and a high-energy-dense diet from fetal life through to 6 months of age. Br. J. Nutr., 2011, 106, 887-895.
30. Sonoyama, K.; Fujiwara, R.; Takemura, N.; Ogasawara, T.; Watanabe, J.; Ito, H. and Morita, T. Response of gut microbiota to fasting and hibernation in Syrian hamsters. Appl. Environ. Microbiol., 2009, 75(20), 6451-6456.
31. Nauck, M.; Frid, A.; Hermansen, K.; Shah, N.S.; Tankova, T.; Mitha, I.H.; Zdravkovic, M.; During, M. and Matthews, D.R. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study. Diabetes Care, 2009, 32(1), 84-90.
32. Suzuki, K.; Jayasena, C.N. and Bloom, S.R. The gut hormones in appetite regulation. J. Obes., 2011, 2011, 528401.
33. Budding, A.; Grasman, M.; Lin, F.; Bogaards, J.; Soeltan-Kaersenhout, D.; Vandenbroucke-Grauls, C.; van Bodegraven, A. and Savelkoul, P. IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota. FASEB J., 2010, 24, 4556-4564.
34. Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Pena, A.G.; Goodrich, J.K.; Gordon, J.I.; Huttley, G.A.; Kelley, S.T.; Knights, D.; Koenig, J.E.; Ley, R.E.; Lozupone, C.A.; McDonald, D.; Muegge, B.D.; Pirrung, M.; Reeder, J.; Sevinsky, J.R.; Turnbaugh, P.J.; Walters, W.A.; Widmann, J.; Yatsunenko, T.; Zaneveld, J. and Knight, R. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods, 2010, 7, 335-336.
35. Turnbaugh, P.; Ley, R.; Mahowald, M.; Magrini, V.; Mardis, E. and Gordon, J. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 2006, 444, 1027-1031.
36. Duncan, S.; Lobley, G. and Holtrop, G. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. (Lond), 2008, 32, 1720-1724.
37. Schwiertz, A.; Taras, D. and Schafer, K. Microbiota and SCFA in lean and overweight healthy subjects. Obesity(Silver Spring), 2010, 18, 190-195.
38. Handschur, M.; Zwielehner, J.; Haslberger, A.G.; Abrat V. and Reid S. Probiotics as alternative medical treatment in gastrointestinal diseaese. Ern�hrung/Nutrition, 31(NR.11), 2007, 459-464.
39. Armougom, F.; Henry, M.; Vialettes, B.; Raccah, D. and Raoult, D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One, 2009, 4(9), e7125.
40. Robinson, E. and Thompson, W. Effect on weight gain of the addition of Lactobacillus acidophilus to the formula of newborn infants. J. Pediatr., 1952, 41, 395-398.
41. Million, M.; Angelakis, E.; Paul, M.; Armougom, F.; Leibovici, L. and Raoult, D. Comperative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microbial. Pathogenesis, 2012, 53, 100-108.
42. Khan, M.; Raoult, D.; Richet, H.; Lepidi, H. and La Scola, B. Growth-promoting effects of single-dose intragastrically administered probiotics in chicken. Br. Poult. Sci., 2007, 48, 732-735.
43. Karlsson, F.H.; Tremaroli, V.; Nookaew, I.; Bergstrom, G.; Behre, C.J.; Fagerberg, B.; Nielsen, J. and Backhed, F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature, 2013, 498(7452), 99-103.
44. Bervoets, L.; Van Hoorenbeeck, K.; Kortleven, I.; Van Noten, C.; Hens, N.; Vael, C.; Goossens, H.; Desager, K. and Vankerckhoven, V. Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog., 2013, 5, 10.
45. Hold, G.; Schwiertz, A.; Aminov, R.; Blaut, M. and Flint, H. Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl. Environ. Microbiol., 2003, 69, 4320-4324.
46. Sokol, H.; Pigneur, B.; Watterlot, L.; Lakhdari, O.; Bermudez-Humaran, L.; Gratadoux, J.; Blugeon, S.; Bridonneau, C.; Furet, J.; Corthier, G.; Grangette, C.; Vasquez, N.; Pochart, P.; Trugnan, G.; Thomas, G.; Blottiere, H.; Dore, J.; Marteau, P.; Seksik, P. and Langella, P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA, 105, 2008, 16731-16736.
47. Murai, M.; Turovskaya, O.; Kim, G.; Madan, R.; Karp, C.; Cheroutre, H. and Kronenberg, M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol., 2009, 10, 1178-1184.
48. Tanaka, K. and Ishikawa, H. Role of intestinal bacterial flora in oral tolerance induction. Histol. Histopathol., 2004, 19, 907-914.
49. Graessler, J.; Qin, Y.; Zhong, H.; Zhang, J.; Licinio, J.; Wong, M.; Xu, A.; Chavakis, T.; Bornstein, A.; Ehrhart-Bornstein, M.; Lamounier-Zepter, V.; Lohmann, T.; Wolf, T. and Bornstein, S. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J., 2012, 13(6), 514-522.
50. Seksik, P.; Sokol, H.; Lepage, P.; Vasquez, N.; Manichanh, C.; Mangin, I.; Pochart, P.; Dore, J. and Marteau, P. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment. Pharmacol. Ther., 2006, 24, 11-18.
51. Raijilic-Stojanovic, M.; Biagi, E.; Heilig, H.; Kajander, K.; Kekkonen, R.; Tims, S. and de Vos, W. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology, 2011, 141, 1792-1801.
52. Sobhani, I.; Tap, J.; Roudot-Thoraval, F.; Roperch, J.; Letulle, S.; Langella, P.; Corthier, G.; van Nhieu, J.T. and Furet, J. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One, 2011, 6, e16393.
53. Wrzosek, L.; Miquel, S.; Noordine, M.; Bouet, S.; Chevalier-Curt, M.; Robert, V.; Philippe, C.; Bridonneau, C.; Cherbuy, C.; Robbe-Masselot, C.; Langella, P. and Thomas, M. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biology, 2013, 11, 61.
54. Wu, X.; Ma, C.; Han, L.; Nawaz, M.; Gao, F.; Zhang, X.; Yu, P.; Zhao, C.; Li, L.; Zhou, A.; Wang, J.; Moore, J.; Millar, B. and Xu, J. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol., 2010, 5, 69-78.
55. Bervoets, L.; Van Hoorenbeek, K.; Kortleven, I.; Van Noten, C.; Hens, N.; Vael, C.; Goossens, H.; Desager, K. and Vankerckhoven, V. Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog., 2013, 5, 10.
56. Wu, H.J. and Wu, E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes, 2012, 3(1), 4-14.
57. Sonnenburg, J. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science, 2005, 5, 1955-1956.
58. Rautio, M.; Eerola, E.; Vaisanen-Trunkelrott, M.; Molitoris, D.; Lawson, P.; Collins, M. and Jousimies-Somer, H. Reclassification of bacteroides putredinis (Weinberg et al., 1937) in a new genus Alistipes gen. nov., as Alistipes putredinis comb. nov., and description of Alistipes finegoldii sp. nov., from human sources. Syst. Appl. Microbiol., 2003, 26, 182-188.
59. Bendtsen, K.B.; Krych, L.; Sorensen, D.; Pang, W.; Nielsen, D.; Josefsen, K.; Hansen, L.; Sorensen, S. and Hansen, A. Gut Microbiota Composition is correlated to Grid Floor Induced Stress and Behavior in the BALB/c Mouse. PLoS One, 2012, 7, e46231.
60. Saulnier, D.; Riehle, K.; Mistretta, T.; Diaz, M.; Mandal, D.; Raza, S.; Weidler, E.; Qin, X.; Coarfa, C.; Milosavljevic, A.; Petrosino, J.; Highlander, S.; Gibbs, R.; Lynch, S.; Shulman, R. and Versalovic, J. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology, 2011, 141, 1782-1791.
61. Martens, E.; Chiang, H. and Gordon, J. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe, 2008, 4, 447-457.
62. Ouwerkerk, J.; de Vos, W. and Belzer, C. Glycobiome: bacteria and mucus at the epithelial interface. Best Pract. Res. Clin. Gastroenterol., 2013, 27, 25-38.
63. Png, C.; Linden, S.; Gilshenan, K.; Zoetendal, E.; McSweeney, C. and Sly, L. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol., 2010, 105, 2420-2428.
64. Zhang, H.; DiBaise, J.; Zuccolo, A.; Kudrna, D.; Braidotti, M.; Yu, Y.; Parameswaran, P.; Crowell, M.; Wing, R.; Rittmann, B. and Krajmalnik-Brown, R. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. USA, 2009, 106, 2365-2370.
65. Swidsinski, A.; Dorffel, Y.; Loening-Baucke, V.; Theissig, F.; Ruckert, J. and Ismail, M. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut, 2011, 60, 34-40.
66. Everard, A.; Lazarevic, V.; Derrien, M.; Girard, M.; Muccioli, G.G.; Neyrinck, A.M.; Possemiers, S.; Van Holle, A.; Francois, P.; de Vos, W.M.; Delzenne, N.M.; Schrenzel, J. and Cani, P.D. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes, 2011, 60(11), 2775-2786.
67. Musso, G.; Gambino, R. and Cassader, M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care, 2010, 33(10), 2277-2284.
68. Brook, I. Anaerobic bacteria in suppurative genitourinary infections. J. Urol., 1989, 141, 889-893.
69. Montejo, M.; Ruiz-Irastorza, G.; Aguirrebengoa, K.; Amutio, E.; Hernandez, J. and Aquirre, C. Prosthetic-valve endocarditis caused by Peptostreptococcus anaerobius. Asia Pacific J. Clin. Nutr., 1995, 20, 1431.
70. Moore, L.; Moore, W. and Cato, E. Bacteriology of human gingivitis. J. Dent. Res., 1987, 66, 989-995.